A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
BioNTech SE
BioNTech SE
DualityBio Inc.
Johns Hopkins University
Genentech, Inc.
Hospital de Clinicas de Porto Alegre
Stanford University
Fred Hutchinson Cancer Center